These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25953283)

  • 1. Advanced magnetic resonance techniques: 3 T.
    Bhatti L; Hoang JK; Dale BM; Bashir MR
    Radiol Clin North Am; 2015 May; 53(3):441-55. PubMed ID: 25953283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0-T functional brain imaging: a 5-year experience.
    Scarabino T; Giannatempo GM; Popolizio T; Tosetti M; d'Alesio V; Esposito F; Di Salle F; Di Costanzo A; Bertolino A; Maggialetti A; Salvolini U
    Radiol Med; 2007 Feb; 112(1):97-112. PubMed ID: 17310287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body MR imaging at 3.0 T: understanding the opportunities and challenges.
    Barth MM; Smith MP; Pedrosa I; Lenkinski RE; Rofsky NM
    Radiographics; 2007; 27(5):1445-62; discussion 1462-4. PubMed ID: 17848702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal magnetic resonance imaging at 3 T: oncological applications.
    Marin D; Husarik DB; Boll DT; Merkle EM
    Top Magn Reson Imaging; 2010 Jun; 21(3):149-56. PubMed ID: 21847034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of epilepsy: state of the art at 1.5 T and potential of 3 T.
    Briellmann RS; Pell GS; Wellard RM; Mitchell LA; Abbott DF; Jackson GD
    Epileptic Disord; 2003 Mar; 5(1):3-20. PubMed ID: 12773291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric high-field magnetic resonance imaging.
    Dahmoush HM; Vossough A; Roberts TP
    Neuroimaging Clin N Am; 2012 May; 22(2):297-313, xi. PubMed ID: 22548934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
    Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
    Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular MR imaging at 3 T: opportunities, challenges, and solutions.
    Rajiah P; Bolen MA
    Radiographics; 2014 Oct; 34(6):1612-35. PubMed ID: 25310420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High field body MR imaging: preliminary experiences.
    Uematsu H; Takahashi M; Dougherty L; Hatabu H
    Clin Imaging; 2004; 28(3):159-62. PubMed ID: 15158217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac MRI of ischemic heart disease at 3 T: potential and challenges.
    Wieben O; Francois C; Reeder SB
    Eur J Radiol; 2008 Jan; 65(1):15-28. PubMed ID: 18077119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of field strength on MR images: comparison of the same subject at 0.5, 1.0, and 1.5 T.
    Maubon AJ; Ferru JM; Berger V; Soulage MC; DeGraef M; Aubas P; Coupeau P; Dumont E; Rouanet JP
    Radiographics; 1999; 19(4):1057-67. PubMed ID: 10464808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Musculoskeletal MR imaging at 3 T.
    Meyer JS; Jaramillo D
    Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):533-45, vi. PubMed ID: 18585603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.
    Fries P; Morelli JN; Lux F; Tillement O; Schneider G; Buecker A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):559-73. PubMed ID: 25196203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.
    Kuhl CK; Träber F; Schild HH
    Radiology; 2008 Mar; 246(3):675-96. PubMed ID: 18309012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3.0-T MR imaging of the abdomen: comparison with 1.5 T.
    Chang KJ; Kamel IR; Macura KJ; Bluemke DA
    Radiographics; 2008; 28(7):1983-98. PubMed ID: 19001653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field].
    Matsusue E; Ogawa T
    Brain Nerve; 2007 May; 59(5):479-85. PubMed ID: 17533973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of 39-potassium MR imaging of a human brain at 9.4 Tesla.
    Atkinson IC; Claiborne TC; Thulborn KR
    Magn Reson Med; 2014 May; 71(5):1819-25. PubMed ID: 23798343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body and cardiovascular MR imaging at 3.0 T.
    Lee VS; Hecht EM; Taouli B; Chen Q; Prince K; Oesingmann N
    Radiology; 2007 Sep; 244(3):692-705. PubMed ID: 17709825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.